Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers
2018 ◽
Vol 42
(2)
◽
pp. 118-123
◽
2002 ◽
Vol 4
(3)
◽
pp. 185-190
◽
2005 ◽
Vol 46
(5)
◽
pp. 821-826
◽
2017 ◽
Vol 24
(18)
◽
pp. 1911-1913
◽
2020 ◽
Vol 44
(1)
◽
pp. 4
◽
2010 ◽
Vol 8
(6)
◽
pp. 742-746
◽